08Aug
FDA Releases New Warning Letter on Human and Animal Hemp CBD Products
On July 22, 2019, the Food and Drug Administration (“FDA”) released its fourth warning letter for cannabidiol (“CBD”) related products since the enactment of the 2018 Federal Farm Bill in December. Though not a formal action or rule-making by the...
By:
Miller & Martin PLLC
Related
The Affordable Care Act’s individual mandate (i.e., the requirement that most individuals obtain ad...
Read More >
As the COVID-19 pandemic continues to disrupt markets and shake the global economy, the full impact ...
Read More >
On January 1, some important changes to Massachusetts employment law took effect. Below are the high...
Read More >
In 2019, OFCCP has been very busy increasing its enforcement activities and issuing policy changes. ...
Read More >
The Second Circuit Court of Appeals recently issued a withdrawal liability decision of which both mu...
Read More >
In the recent case, Hong Kong Exchanges and Clearing Limited v. Shi Huaifang [2019] HKCFI 1212, the ...
Read More >